Ritesh Kaushal, MD
Vascular Neurology · Hialeah, FLNPI 1710298138
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Penumbra, Inc. at 50.5% of the total.
Across 60 payments — averaging $113.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Corindus Inc.$1K
- Stryker$664
- Boston Scientific$280
- Johnson & Johnson$274
- Medtronic$235
- plus $762 from 6 others
Across 8 payments — averaging $1613.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Penumbra, Inc.$10K
- Boehringer Ingelheim$2K
- Stryker$2K
What the payments were for
- Speaking & faculty fees$2,40035%
- Travel & lodging$1,14017%
- Food & beverage$3,25348%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 11 | $3,432 |
| Corindus Inc. | 4 | $1,146 |
| Stryker | 9 | $664 |
| Boston Scientific | 3 | $280 |
| Johnson & Johnson | 9 | $274 |
| Medtronic(2 entities) | 11 | $235 |
| Imperative Care, Inc | 6 | $182 |
| Abbott | 2 | $163 |
| Rapid Medical Ltd | 1 | $157 |
| Lilly USA, LLC | 1 | $125 |
| Genentech USA, Inc. | 1 | $103 |
| AbbVie | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$2,921
- CorPath GRX$1,124
- TARGET$313
- RED 72$166
- BROADWAY 8$159
- SURPASS EVOLVE$159
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$157
- COMANECI 17$157
- NEUROFORM ATLAS$154
- AXS INFINITY LS$154
- TREVO$146
- INFINITY$146
- CATALYST$146
- GENERAL VASCULAR INTERVENTION$139
- AMPLATZER Occluders$130
- ZEPBOUND$125
- Activase$103
How this compares
$6,793 in reported general payments places this provider in the 70th percentile of 40 vascular neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Hialeah
- Maxim MokinTampa$137K
- Robert MannelJacksonville Beach$92K
- Alexander SenetarSarasota$42K
- Amin AghaebrahimJacksonville$36K
- Miguel ChuquilinTallahassee$30K
- Richard CallisonFort Pierce$28K
- Farah FourcandVero Beach$11K
- John CasselTampa$10K
- William BurginTampa$9K
- Mehdi BouslamaFort Lauderdale$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.